Eisai and Biogen Make LEQEMBI Pen Available in Japan
The companies said the subcutaneous formulation of LEQEMBI is now available in Japan for patients with early Alzheimer’s disease.
The companies said the subcutaneous formulation of LEQEMBI is now available in Japan for patients with early Alzheimer’s disease.